Wenlai Zhou
Chairman & CEO
Dr. Zhou has multi-discipline expertise from both academic and industrial background with over 20 years’ experience in drug discovery and development and he founded Danatlas Pharmaceuticals as Chairman and CEO in 2021.
From 2015 to 2021, he served as SVP and CBO at Jacobio Pharmaceuticals, managing more than 10 R&D pipelines. Notably, he also directed the landmark licensing of SHP2 inhibitor program to AbbVie and co-led its advancement into Phase II trials as a JSC key member.
Earlier at Novartis Oncology (2009-2015) as Lab Head, he successfully led several first-in-class small molecules and siRNA programs from target discovery to Phase I studies.
He holds a Ph.D. in Molecular Biology from the University of Melbourne and completed postdoctoral training at UC San Diego School of Medicine, trained under internationally renowned scientist Michael G. Rosenfeld, a dual-elected member of the US National Academy of Sciences and National Academy of Medicine.
Hongmei Li
Co-founder, Chief Operating Officer
Li Hongmei currently serves as the Chief Operating Officer at Danatlas Pharmaceuticals.
Li Hongmei has over 18 years’ experience of operational management in technology-driven R&D enterprises. She has deeply involved in the full-cycle of capitalization management of pharmaceutical companies such as Jacobio Pharmaceuticals (HKEX: 1167.HK) and Betta Pharmaceuticals (SZSE: 300558.SZ). She also established integrated risk control systems encompassing finance, human resources, legal affairs, and investment & financing.
Li Hongmei previously served as Vice President of Jinlan Gene, Administrative Director & HR Director at Jacobio Pharmaceuticals, and Head of the HR Department in the New Drug R&D Center at Betta Pharmaceuticals. She played a key role in building internal control management systems of these companies, covering finance, legal affairs, human resources, government relations, investor relations, corporate planning, and brand development. She has extensive experience in corporation risk control, building international organizational system, and investment & financing.
Li Hongmei holds a Master’s degree in Public Administration from Renmin University of China and a Bachelor’s degree in Accounting from the Department of Management, Chengdu University of Information Technology.
